Life Matters Company
"New Modality for Fighting Resistant Bacteria via Biofilm Elimination."
Life Matters is a pre-clinical-stage biopharmaceutical company dedicated to improving the pipeline for tackling antibiotic-resistant bacteria. The company develops New Modality to fight resistant bacteria which are often acquired in hospitals, by preventing its biofilm mode of growth. This results in a more treatable infection.
Morbidity & mortality in chronic lung infections are often due to biofilm associated P. aeruginosa. By eliminating the bacterial biofilm, the company enables the innate immune system to eradicate the infection.
Life Matters' small molecules do not possess any selection pressure towards the bacteria, a resistant creating mechanism which emphasis the resistant strains. Moreover, the compounds have a broad activity against various gram negative and positive pathogens.
Life Matters' lead API, IBF-2 is a compound with an innovative mechanism of action, can attenuate the biofilm mode of growth, a crucial phenotype allowing bacteria to survive despite environmental stresses such as antibacterial agents or the host immune system cell.
Combating Coronavirus Pandemic:
Life Matters's solution helps address the Coronavirus Pandemic.
Life Matters is a pre-clinical-stage biopharmaceutical company dedicated to improving the pipeline for tackling antibiotic-resistant bacteria. The company develops New Modality to fight resistant bacteria which are often acquired in hospitals, by preventing its biofilm mode of growth. This results in a more treatable infection.
Morbidity & mortality in chronic lung infections are often due to biofilm associated P. aeruginosa. By eliminating the bacterial biofilm, the company enables the innate immune system to eradicate the infection.
Life Matters' small molecules do not possess any selection pressure towards the bacteria, a resistant creating mechanism which emphasis the resistant strains. Moreover, the compounds have a broad activity against various gram negative and positive pathogens.
Life Matters' lead API, IBF-2 is a compound with an innovative mechanism of action, can attenuate the biofilm mode of growth, a crucial phenotype allowing bacteria to survive despite environmental stresses such as antibacterial agents or the host immune system cell.
Combating Coronavirus Pandemic:
Life Matters's solution helps address the Coronavirus Pandemic.
Technology:
COVID Treatments
Industry:
Treatment Development
Headquarters:
Israel
Founded Date:
2016
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership